首页>
美国卫生研究院文献>Springer Open Choice
>Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature
【2h】
Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature
Idiopathic hypertrophic cranial pachymeningitis (IHCP) is a rare clinical entity, characterized by a chronic inflammation causing thickening of the dura. Adequate therapeutic management is still a matter of debate. We present a patient with an IHCP, non-responsive to corticotherapy. Oral methotrexate was introduced (12.5 mg weekly) and total remission was observed after 6 weeks, both clinically and after neuro-imaging. We conclude that methotrexate can be effective and a therapeutical option in patients with IHCP who are resistant to corticotherapy or present major side-effects of chronic corticosteroids use.
展开▼